Gerd R Burmester Selected Research

Janus Kinase Inhibitors

4/2024	Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials.
1/2024	Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years.
1/2023	EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
4/2022	Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials.
2/2022	Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment.
1/2022	Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database.
1/2021	Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme.
1/2020	EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
1/2020	Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis.
1/2020	An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational Data.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gerd R Burmester Research Topics

Disease

125	Rheumatoid Arthritis 04/2024 - 05/2003
23	Infections 04/2024 - 05/2008
20	Psoriatic Arthritis 04/2024 - 04/2005
18	Necrosis 12/2023 - 06/2007
14	Arthritis (Polyarthritis) 03/2024 - 08/2004
13	Inflammation (Inflammations) 02/2024 - 11/2004
12	Rheumatic Diseases (Rheumatism) 03/2023 - 05/2010
11	Pain (Aches) 12/2023 - 10/2012
11	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 05/2003
10	Herpes Zoster 04/2024 - 01/2018
10	Ankylosing Spondylitis 04/2024 - 08/2009
9	Neoplasms (Cancer) 04/2024 - 04/2013
9	Fatigue 01/2022 - 01/2006
8	COVID-19 12/2023 - 01/2020
8	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 09/2008
6	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2024 - 04/2005
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2023 - 01/2006
6	Chronic Disease (Chronic Diseases) 01/2022 - 10/2012
5	Connective Tissue Diseases (Connective Tissue Disease) 05/2022 - 01/2009
5	Vasculitis (Vasculitides) 01/2022 - 05/2004
5	Osteoarthritis 01/2021 - 08/2004
4	Skin Neoplasms (Skin Cancer) 04/2024 - 04/2013
4	Headache (Headaches) 10/2023 - 02/2013
4	Nasopharyngitis 04/2022 - 02/2013
4	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2022 - 04/2013
4	Fibrosis (Cirrhosis) 01/2018 - 01/2009
3	Melanoma (Melanoma, Malignant) 01/2023 - 04/2013
3	Respiratory Tract Infections (Respiratory Tract Infection) 04/2022 - 01/2018
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 01/2009
3	Disease Progression 01/2020 - 03/2011
3	Injection Site Reaction 05/2017 - 11/2010
3	digital ulcers 01/2009 - 09/2008
2	Non-Radiographic Axial Spondyloarthritis 04/2024 - 01/2020
2	Axial Spondyloarthritis 04/2024 - 07/2012
2	Synovitis 02/2024 - 05/2004
2	Venous Thromboembolism 01/2024 - 01/2020
2	Anemia 04/2022 - 08/2009
2	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2022 - 07/2017
2	Urinary Tract Infections (Urinary Tract Infection) 01/2021 - 02/2013
2	Ulcerative Colitis 01/2021 - 01/2020
2	Crohn Disease (Crohn's Disease) 01/2020 - 04/2013
2	Nausea 01/2018 - 02/2013

Drug/Important Bio-Agent (IBA)

32	Methotrexate (Mexate)FDA LinkGeneric 03/2024 - 01/2009
29	Antirheumatic Agents (DMARD)IBA 04/2024 - 04/2005
20	Adalimumab (Humira)FDA Link 04/2024 - 06/2007
17	tocilizumab (atlizumab)FDA Link 01/2023 - 05/2011
14	sarilumabIBA 10/2023 - 01/2017
14	CytokinesIBA 05/2022 - 09/2003
13	Biomarkers (Surrogate Marker)IBA 12/2022 - 06/2007
12	Janus Kinase InhibitorsIBA 04/2024 - 02/2013
12	Abatacept (Orencia)FDA Link 02/2024 - 01/2014
12	tofacitinibIBA 12/2023 - 02/2013
11	upadacitinibIBA 04/2024 - 12/2016
10	Rituximab (Mabthera)FDA Link 01/2023 - 08/2009
9	Interleukin-6 (Interleukin 6)IBA 11/2023 - 01/2009
9	GLPG0634IBA 07/2023 - 01/2020
9	AutoantibodiesIBA 01/2023 - 05/2003
8	InterleukinsIBA 03/2024 - 04/2007
8	GlucocorticoidsIBA 09/2023 - 01/2016
8	Monoclonal AntibodiesIBA 01/2018 - 09/2011
7	ametantrone (HAQ)IBA 12/2023 - 10/2012
7	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 05/2011
7	AntibodiesIBA 01/2018 - 05/2004
6	baricitinibIBA 12/2023 - 01/2019
6	Infliximab (Remicade)FDA Link 01/2023 - 04/2005
6	Etanercept (Enbrel)FDA Link 01/2023 - 05/2009
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 09/2003
5	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 11/2023 - 04/2013
5	golimumab FDA Link 01/2023 - 01/2018
5	Leflunomide (Arava)FDA LinkGeneric 01/2023 - 01/2018
5	AntigensIBA 01/2022 - 11/2006
5	AutoantigensIBA 01/2020 - 05/2003
5	mavrilimumabIBA 01/2018 - 09/2011
4	VaccinesIBA 12/2023 - 01/2022
4	omega-Chloroacetophenone (Mace)IBA 01/2023 - 01/2019
4	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2023 - 07/2012
4	Certolizumab Pegol FDA Link 01/2023 - 01/2009
4	Biosimilar PharmaceuticalsIBA 01/2023 - 03/2013
4	C-Reactive ProteinIBA 01/2022 - 08/2009
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2018 - 09/2011
3	acetyl 4-aminosalicylic acidIBA 02/2024 - 07/2017
3	Creatine Kinase (Creatine Phosphokinase)IBA 01/2023 - 01/2021
3	Immunoglobulins (Immunoglobulin)IBA 05/2022 - 05/2008
3	ChemokinesIBA 05/2022 - 05/2004
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2021 - 04/2012
3	Rheumatoid FactorIBA 05/2016 - 05/2004
2	Anti-Citrullinated Protein AntibodiesIBA 02/2024 - 07/2017
2	Interleukin-12 (IL 12)IBA 12/2023 - 01/2020
2	Antiviral Agents (Antivirals)IBA 03/2023 - 01/2020
2	vinyltriethoxysilane (VTES)IBA 04/2022 - 01/2021
2	LigandsIBA 01/2022 - 04/2013
2	Interferon Type IIBA 01/2022 - 08/2017
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 10/2014
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2012
2	Immunologic Factors (Immunomodulators)IBA 01/2021 - 02/2013
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2006
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 05/2004
2	EpitopesIBA 01/2020 - 01/2018

Therapy/Procedure

45	Therapeutics 03/2024 - 11/2004
2	Drug Tapering 01/2020 - 01/2018